nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry
|
Terry, Mary Beth |
|
|
106 |
2 |
p. 281-288 |
artikel |
2 |
Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry
|
Terry, Mary Beth |
|
2007 |
106 |
2 |
p. 281-288 |
artikel |
3 |
A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer
|
Rasmussen, Louise M. |
|
2007 |
106 |
2 |
p. 191-203 |
artikel |
4 |
A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models
|
Ishida, Hiroyuki |
|
|
106 |
2 |
p. 215-227 |
artikel |
5 |
A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models
|
Ishida, Hiroyuki |
|
2007 |
106 |
2 |
p. 215-227 |
artikel |
6 |
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
|
Purnomosari, Dewajani |
|
2007 |
106 |
2 |
p. 297-304 |
artikel |
7 |
Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications
|
Rusby, Jennifer E. |
|
|
106 |
2 |
p. 171-179 |
artikel |
8 |
Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications
|
Rusby, Jennifer E. |
|
2006 |
106 |
2 |
p. 171-179 |
artikel |
9 |
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial
|
Locker, Gershon Y. |
|
2007 |
106 |
2 |
p. 229-238 |
artikel |
10 |
Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling
|
Beristain, E. |
|
2007 |
106 |
2 |
p. 255-262 |
artikel |
11 |
Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors
|
Eisner, Alvin |
|
2007 |
106 |
2 |
p. 161-170 |
artikel |
12 |
Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI
|
Ouwerkerk, Ronald |
|
2007 |
106 |
2 |
p. 151-160 |
artikel |
13 |
Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women
|
Wang, Jun |
|
2007 |
106 |
2 |
p. 273-280 |
artikel |
14 |
Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk
|
Vaclavicek, Annika |
|
|
106 |
2 |
p. 205-213 |
artikel |
15 |
Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk
|
Vaclavicek, Annika |
|
2007 |
106 |
2 |
p. 205-213 |
artikel |
16 |
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
|
Macis, Debora |
|
|
106 |
2 |
p. 263-271 |
artikel |
17 |
Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis
|
Macis, Debora |
|
2007 |
106 |
2 |
p. 263-271 |
artikel |
18 |
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families
|
Buffone, Amelia |
|
|
106 |
2 |
p. 289-296 |
artikel |
19 |
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families
|
Buffone, Amelia |
|
2007 |
106 |
2 |
p. 289-296 |
artikel |
20 |
Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients
|
Becker, Sven |
|
2007 |
106 |
2 |
p. 239-243 |
artikel |
21 |
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer
|
Arriola, Edurne |
|
|
106 |
2 |
p. 181-189 |
artikel |
22 |
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer
|
Arriola, Edurne |
|
2007 |
106 |
2 |
p. 181-189 |
artikel |
23 |
Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival
|
Yun, Young Ho |
|
|
106 |
2 |
p. 245-253 |
artikel |
24 |
Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival
|
Yun, Young Ho |
|
2007 |
106 |
2 |
p. 245-253 |
artikel |